Party drug's brain tricks explained for first time

October 31, 2011 in Medical research

(Medical Xpress) -- A researcher at the University of Sydney has discovered how the increasingly common street drug mephedrone affects the brain, helping to explain why it is potentially such an addictive substance.

A party drug also known by the street name 'meow meow', mephedrone works like a combination of (crystal meth or ice) and MDMA (commonly known as ecstasy), explains PhD student Craig Motbey.

He used an advanced technique to trace the effect of mephedrone on . "When you look at the pattern of neurons activated by the mephedrone, it is as if the effect of ecstasy and the effect of methamphetamine on the brain's neurons had been laid on top of each other," he said.

"The findings confirm the anecdotal reports from mephedrone users that the drug combines the euphoric, sociable effects of ecstasy with an addictive hook comparable to drugs such as or methamphetamine."

The research, which has been published online in the journal Addiction Biology ahead of print publication, uses a technique called c-Fos, which tracks that indicate which neurons were activated by mephedrone consumption.

The brains of rats which were dosed with mephedrone were compared to those that weren't, allowing researchers to detect which were reacting to the drug.

"Mephedrone is similar to ecstasy but with a strong addictive component. Rats really like this drug, they'll spend hours working to get it," Motbey said.

Mephedrone is a relatively new recreational drug that has been available in Australia for approximately two years. It is already in widespread use in the UK and Europe, and is one of the so-called created to circumvent bans on existing drugs.

Motbey's supervisor and co-author of the paper, Professor Iain McGregor, will lead a project that has just received $386,250 from the National Health and Medical Research Council to study mephedrone's effects on the in more detail, including the long term damage to users.

The work will be done in conjunction with Dr. Adam Winstock at the UK National Addiction Centre, London, a leading authority on mephedrone.

"Mephedrone is one of the new breed of party drugs that are exploding in popularity around the world," said Professor McGregor, head of the University of Sydney's Psychopharmacology Laboratory.

"The evolution of party drugs is very rapid at present, and the chemistry behind them is often clever and devious. Scientists and health authorities must move urgently to define the psychological and physical dangers these drugs pose to young people."

Provided by University of Sydney

5 /5 (1 vote)  

Rank 5 /5 (1 vote)
Related Stories
Relevant PhysicsForums posts

More news stories

H. pylori, smoking trends, and gastric cancer in US men

Trends in Helicobacter pylori (H. pylori) and smoking explain a significant proportion of the decline of intestinal-type noncardia gastric adenocarcinoma (NCGA) incidence in US men between 1978 and 2008, and are estimated ...

Medical research created 11 hours ago | popularity not rated yet | comments 0

Common food supplement fights degenerative brain disorders

Widely available in pharmacies and health stores, phosphatidylserine is a natural food supplement produced from beef, oysters, and soy. Proven to improve cognition and slow memory loss, it's a popular treatment for older ...

Medical research created 16 hours ago | popularity 5 / 5 (3) | comments 0 | with audio podcast

Finding a family for a pair of orphan receptors in the brain

Researchers at Emory University have identified a protein that stimulates a pair of "orphan receptors" found in the brain, solving a long-standing biological puzzle and possibly leading to future treatments for neurological ...

Medical research created 16 hours ago | popularity 5 / 5 (1) | comments 0 | with audio podcast

Insight into the dazzling impact of insulin in cells

Australian scientists have charted the path of insulin action in cells in precise detail like never before. This provides a comprehensive blueprint for understanding what goes wrong in diabetes.

Medical research created 17 hours ago | popularity 4.6 / 5 (7) | comments 0 | with audio podcast

Do men's and women's hearts burn fuel differently?

Researchers at the University of Illinois at Chicago College of Medicine will study gender differences in how the heart uses and stores fat—its main energy source—and how changes in fat metabolism play ...

Medical research created 20 hours ago | popularity not rated yet | comments 0


Phthalates: Study links chemicals widely found in plastics, processed food to elevated blood pressure in children, teens

Plastic additives known as phthalates (pronounced THAL-ates) are odorless, colorless and just about everywhere: They turn up in flooring, plastic cups, beach balls, plastic wrap, intravenous tubing and—according to the ...

If you can remember it, you can remember it wrong

(Medical Xpress)—Native peoples in regions where cameras are uncommon sometimes react with caution when their picture is taken. The fear that something must have been stolen from them to create the photo ...

B vitamins could delay dementia

(Medical Xpress)—Despite spending billions of dollars on research and development, drug companies have been unable to come up with effective treatments for dementia and Alzheimer's Disease (AD). Now, A. ...

New sleeping pill poised to hit US markets

An experimental sleeping pill from US drug company Merck is effective at helping people fall and stay asleep, according to reviewers at the US Food and Drug Administration, which could soon approve the new drug.

Reducing caloric intake delays nerve cell loss

Activating an enzyme known to play a role in the anti-aging benefits of calorie restriction delays the loss of brain cells and preserves cognitive function in mice, according to a study published in the May ...

Antidepressant reduces stress-induced heart condition

A drug commonly used to treat depression and anxiety may improve a stress-related heart condition in people with stable coronary heart disease, according to researchers at Duke Medicine.